Status:
RECRUITING
Exploring the Genetics of Neuropathic Pain
Lead Sponsor:
Oslo University Hospital
Collaborating Sponsors:
Haukeland University Hospital
Helse Stavanger HF
Conditions:
Neuropathic Pain
Genetic Predisposition
Eligibility:
All Genders
18-70 years
Brief Summary
In the present study the investigators will search for new genetic variants relevant for the development of neuropathic pain.
Detailed Description
Neuropathic pain is defined as "pain caused by a lesion or disease of the somatosensory nervous system". Neuropathic pain is a huge health problem worldwide, with an estimated prevalence of 7-8 % in t...
Eligibility Criteria
Inclusion
- The patient is between 18 and 70 years old.
- The patient has consented.
- The patient is referred for evaluation of possible distal symmetric polyneuropathy (DSPN).
- The patient has filled out the questionnaires.
Exclusion
- The patient is too sick to participate (eg. bedridden, fever).
- The patient is unable to consent (eg. dementia, speech problems, psychiatric disorder).
- Inflammatory acute polyneuropathy.
Key Trial Info
Start Date :
August 1 2018
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2027
Estimated Enrollment :
5000 Patients enrolled
Trial Details
Trial ID
NCT03862365
Start Date
August 1 2018
End Date
December 31 2027
Last Update
November 7 2023
Active Locations (5)
Enter a location and click search to find clinical trials sorted by distance.
1
Haukeland University Hospital
Bergen, Norway, 5021
2
Oslo University Hospital
Oslo, Norway, 0450
3
Helse Stavanger HF
Stavanger, Norway, 4011
4
University Hospital of North Norway
Tromsø, Norway, 9019